V011-1232 Screening compound: N-[5-({4-[6-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-1,3-thiazol-2-yl]acetamide

V011-1232 Screening compound: N-[5-({4-[6-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-1,3-thiazol-2-yl]acetamide
V011-1232 Screening compound: N-[5-({4-[6-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-1,3-thiazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-1232
N-[5-({4-[6-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-1,3-thiazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-1232

Molecular Formula

C23H26N8O5S2 (C23 H26 N8 O5 S2)

Compound Name

N-[5-({4-[6-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-1,3-thiazol-2-yl]acetamide

IUPAC name

N-[5-({4-[6-(34-dimethoxyphenyl)-[124]triazolo[15-a]pyrimidin-7-yl]piperazin-1-yl}sulfonyl)-4-methyl-13-thiazol-2-yl]acetamide

SMILES

CC(Nc(s1)nc(C)c1S(N(CC1)CCN1c(n1ncnc1nc1)c1-c(cc1)cc(OC)c1OC)(=O)=O)=O

InChI

InChI=1S/C23H26N8O5S2/c1-14-21(37-23(27-14)28-15(2)32)38(33,34)30-9-7-29(8-10-30)20-17(12-24-22-25-13-26-31(20)22)16-5-6-18(35-3)19(11-16)36-4/h5-6,11-13H,7-10H2,1-4H3,(H,27,28,32)

InChI Key

UPMNXDDGWNAAHF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19961058

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

558.64

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

13

Partition Coefficient, logP

2.072

Distribution Coefficient, logD

1.770

Water Solubility, LogSw

-3.00

Polar Surface Area

114.913

Acid Dissociation Constant (pKa)

7.41

Base Dissociation Constant (pKb)

5.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

V011-1232 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V011-1232 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-1232?
Check Price and Availability of V011-1232, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-1232 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-1232
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-1232
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-1232 available by request